Estimating the true value: Aducanumab and Donanemab for Early Alzheimer Disease Hole Ousia 3 years ago Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Donanemab: bleeding and seizuresDateJuly 20, 2023In relation toAlzheimer's diseaseBrain volume loss due to DonanemabDateJuly 20, 2023In relation toAlzheimer's diseaseDonanemab:’The results may be misleading’DateJuly 20, 2023In relation toAlzheimer's disease
